Log In
Print this Print this

BioChaperone insulin (HinsBet)

  Manage Alerts
Collapse Summary General Information
Company Adocia S.A.
DescriptionFast-acting formulation of recombinant human insulin using BioChaperone polymer technology
Molecular Target Insulin receptor (INSR)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type I and Type II diabetes; Treat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today